(Q78794127)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12527909%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

title

Tumor regression by combination antisense therapy against Plk1 and Bcl-2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12527909%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12527909%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

2

Albrecht Piiper

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12527909%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

Robert Elez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12527909%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Bernd Kronenberger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12527909%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Martin Kock

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12527909%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Eva Hermann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12527909%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Uwe Pliquett

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12527909%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Eberhardt Neumann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12527909%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Stefan Zeuzem

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12527909%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

language of work or name

English

0 references

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12527909%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12527909%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12527909%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12527909%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

69-80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12527909%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206038

16 December 2019

exact match

0 references

cites work

Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Inhibition of Bax channel-forming activity by Bcl-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Myogenic expression of an injectable protease-resistant growth hormone-releasing hormone augments long-term growth in pigs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Polo-like kinase1, a new target for antisense tumor therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Bcl-2 expression in malignant melanoma and its prognostic significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Inhibition of coagulation by a phosphorothioate oligonucleotide.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

PKA and MPF-activated polo-like kinase regulate anaphase-promoting complex activity and mitosis progression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Cell cycle- and terminal differentiation-associated regulation of the mouse mRNA encoding a conserved mitotic protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Order of function of the budding-yeast mitotic exit-network proteins Tem1, Cdc15, Mob1, Dbf2, and Cdc5

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Molecular profiling of human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Bcl-x(L) forms an ion channel in synthetic lipid membranes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Fundamentals of electroporative delivery of drugs and genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Gene transfer into mouse lyoma cells by electroporation in high electric fields

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Control of the DNA damage checkpoint by chk1 and rad53 protein kinases through distinct mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Polo-like kinase-1 is a target of the DNA damage checkpoint

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Does antisense exist?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Inhibition of Polo-like kinase-1 by DNA damage occurs in an ATM- or ATR-dependent fashion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Antisense technology and prospects for therapy of viral infections and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIalpha subunit of protein kinase A after oral administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

BCL-2 antisense therapy in patients with non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021

Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206038

7 January 2021